Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $17.33B | $15.84B | +9.43% |
Cost of Revenue | $5.98B | $6.44B | -7.10% |
Operating Income | $3.83B | $2.9B | +32.21% |
Net Income | $3.16B | $633M | +399.53% |
EPS (Basic) | $5.88 | $1.18 | +398.31% |
EPS (Diluted) | $5.84 | $1.17 | +399.15% |
SG&A Expense | $3.38B | $3.59B | -5.98% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $87.9B | $90.91B | -3.31% |
Current Assets | $26.73B | $27.21B | -1.73% |
Current Liabilities | $20.48B | $21.52B | -4.84% |
Stockholders' Equity | $7.43B | $5.92B | +25.37% |
Cash & Equivalents | $8.03B | $9.3B | -13.69% |
Long-Term Debt | $56.2B | $62.65B | -10.28% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $3.67B | $3.15B | +16.61% |
Investing Cash Flow | $-836M | $-434M | -92.63% |
Financing Cash Flow | $-6.78B | $-4.36B | -55.61% |
D&A | $2.73B | $2.8B | -2.54% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | 22.1% | 18.3% | +3.81% |
Net Margin | 18.2% | — | — |
ROE | 42.6% | — | — |
ROA | 3.6% | — | — |
Current Ratio | $1.306 | — | — |
Other companies in Biotechnology